SETD2 Antibody

Polyclonal Antibody

SETD2

EC 2.1.1.43 antibody, FLJ16420 antibody, FLJ22472 antibody, FLJ23184 antibody, FLJ45883 antibody, HBP231 antibody, HIF 1 antibody, HIF-1 antibody, HIF1 antibody, HIP-1 antibody, Histone lysine N methyltransferase SETD2 antibody, Histone-lysine N-methyltransferase SETD2 antibody, hSET2 antibody, HSPC069 antibody, Huntingtin interacting protein 1 antibody, Huntingtin interacting protein antibody, Huntingtin interacting protein B antibody, Huntingtin interacting protein HYPB antibody, Huntingtin yeast partner B antibody, Huntingtin-binding protein, 231-KD antibody, Huntingtin-interacting protein 1 antibody, Huntingtin-interacting protein B antibody, HYPB antibody, KIAA1732 antibody, KMT3A antibody, Lysine N methyltransferase 3A antibody, Lysine N-methyltransferase 3A antibody, p231HBP antibody, SET domain containing 2 antibody, SET domain-containing protein 2 antibody, SET2 antibody, SETD2 antibody, SETD2_HUMAN antibody

Fusion protein of human SETD2

Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II.

Antigen Affinity Purified

Epigenetics and Nuclear Signaling

Fusion protein of Human SETD2